|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 199.89 USD | -0.23% |
|
-8.25% | +12.67% |
| 09/07 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| 08/07 | BofA Securities Adjusts Biogen Price Target to $217 From $203 | MT |
| Market Cap | 29.58B 25.95B 23.95B 22.13B 41.95B 2,832B 42.79B 288B 112B 1,386B 111B 109B 4,812B | P/E 2026 * |
30.5x | P/E 2027 * | 16.8x |
|---|---|---|---|---|---|
| Enterprise Value | 35.09B 30.78B 28.41B 26.26B 49.77B 3,360B 50.76B 342B 133B 1,644B 132B 129B 5,708B | EV / Sales 2026 * |
3.5x | EV / Sales 2027 * | 3.19x |
| Free-Float |
85.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biogen Inc.
| 1 day | -0.24% | ||
| 1 week | -8.25% | ||
| Current month | -8.22% | ||
| 1 month | -0.41% | ||
| 3 months | +11.96% | ||
| 6 months | +5.69% | ||
| Current year | +12.67% |
| 1 week | 196 |  | 215.95 |
| 1 month | 193.2 | | 219.72 |
| Current year | 160.36 | | 219.72 |
| 1 year | 121.05 | | 219.72 |
| 3 years | 110.04 | | 282.74 |
| 5 years | 110.04 | | 358.77 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Guy Hadari
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Chairman | 2,005 | 0.0014% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.23% | -8.25% | +49.07% | -29.58% | 29.58B | |
| +0.17% | +1.57% | +20.26% | -5.52% | 67.44B | |
| +1.25% | -4.84% | +47.86% | +221.01% | 53.98B | |
| -4.15% | +36.30% | +36.30% | +36.30% | 41.77B | |
| +0.99% | +6.61% | -48.49% | -52.47% | 41.15B | |
| +3.33% | -4.85% | +131.46% | -38.34% | 29.28B | |
| +0.50% | +1.13% | +71.97% | +90.95% | 23.43B | |
| +0.17% | +1.17% | +4.98% | +190.25% | 19.11B | |
| +1.12% | -0.42% | +68.41% | +133.89% | 16.82B | |
| +15.42% | +17.27% | +96.87% | +421.43% | 15.36B | |
| Average | +1.89% | +2.05% | +47.87% | +96.79% | 33.79B | |
| Weighted average by Cap. | +0.93% | +1.69% | +39.04% | +69.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.04B 8.8B 8.13B 7.51B 14.24B 961B 14.52B 97.7B 37.96B 470B 37.69B 36.86B 1,633B | 10.35B 9.07B 8.38B 7.74B 14.67B 991B 14.97B 101B 39.13B 485B 38.85B 38B 1,683B |
| Net income | 1.51B 1.33B 1.22B 1.13B 2.15B 145B 2.19B 14.73B 5.72B 70.88B 5.68B 5.56B 246B | 1.95B 1.71B 1.58B 1.46B 2.76B 186B 2.82B 18.96B 7.37B 91.26B 7.31B 7.15B 317B |
| Net Debt | 5.51B 4.83B 4.46B 4.12B 7.81B 527B 7.97B 53.63B 20.84B 258B 20.69B 20.23B 896B | 3.38B 2.97B 2.74B 2.53B 4.8B 324B 4.9B 32.95B 12.8B 159B 12.71B 12.43B 551B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | USD 198.29 | -1.03% | 167,655 |
| 08/07/26 | USD 200.36 | -2.60% | 1,947,888 |
| 07/07/26 | USD 205.70 | -1.32% | 1,156,880 |
| 06/07/26 | USD 208.46 | -3.54% | 1,218,492 |
| 02/07/26 | USD 216.12 | +3.04% | 1,155,165 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
